We provide you with 20 years of free, institutional-grade data for CDNA stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of CDNA. Explore the full financial landscape of CDNA stock.
| Reported Date | CIK | Ticker | Type | |
|---|---|---|---|---|
| 2024-02-28 | 1217234 | CDNA | 10-K | Url |
| 2023-11-08 | 1217234 | CDNA | 10-Q | Url |
| 2023-08-08 | 1217234 | CDNA | 10-Q | Url |
| 2023-05-10 | 1217234 | CDNA | 10-Q | Url |
| 2023-02-27 | 1217234 | CDNA | 10-K | Url |
| 2022-11-03 | 1217234 | CDNA | 10-Q | Url |
| 2022-08-04 | 1217234 | CDNA | 10-Q | Url |
| 2022-05-05 | 1217234 | CDNA | 10-Q | Url |
| 2022-02-24 | 1217234 | CDNA | 10-K | Url |
| 2021-10-28 | 1217234 | CDNA | 10-Q | Url |
| 2021-07-29 | 1217234 | CDNA | 10-Q | Url |
| 2021-05-05 | 1217234 | CDNA | 10-Q | Url |
| 2021-02-24 | 1217234 | CDNA | 10-K | Url |
| 2020-10-29 | 1217234 | CDNA | 10-Q | Url |
| 2020-08-04 | 1217234 | CDNA | 10-Q | Url |
| 2020-04-30 | 1217234 | CDNA | 10-Q | Url |
| 2020-02-28 | 1217234 | CDNA | 10-K | Url |
| 2019-10-31 | 1217234 | CDNA | 10-Q | Url |
| 2019-08-01 | 1217234 | CDNA | 10-Q | Url |
| 2019-05-08 | 1217234 | CDNA | 10-Q | Url |
| 2019-03-06 | 1217234 | CDNA | 10-K | Url |
| 2018-11-08 | 1217234 | CDNA | 10-Q | Url |
| 2018-08-09 | 1217234 | CDNA | 10-Q | Url |
| 2018-05-10 | 1217234 | CDNA | 10-Q | Url |
| 2018-03-22 | 1217234 | CDNA | 10-K | Url |
| 2017-11-09 | 1217234 | CDNA | 10-Q | Url |
| 2017-09-01 | 1217234 | CDNA | S-1 | Url |
| 2017-08-25 | 1217234 | CDNA | S-1 | Url |
| 2017-08-11 | 1217234 | CDNA | 10-Q | Url |
| 2017-06-09 | 1217234 | CDNA | 10-Q | Url |
| 2017-04-26 | 1217234 | CDNA | S-1 | Url |
| 2017-04-21 | 1217234 | CDNA | 10-K | Url |
| 2016-11-14 | 1217234 | CDNA | 10-Q | Url |
| 2016-08-22 | 1217234 | CDNA | 10-Q | Url |
| 2016-05-16 | 1217234 | CDNA | 10-Q | Url |
| 2016-03-29 | 1217234 | CDNA | 10-K | Url |
| 2015-11-13 | 1217234 | CDNA | 10-Q | Url |
| 2015-08-12 | 1217234 | CDNA | 10-Q | Url |
| 2015-05-14 | 1217234 | CDNA | 10-Q | Url |
| 2015-03-31 | 1217234 | CDNA | 10-K | Url |
| 2014-11-14 | 1217234 | CDNA | 10-Q | Url |
| 2014-08-28 | 1217234 | CDNA | 10-Q | Url |
| 2014-06-03 | 1217234 | CDNA | S-1 | Url |
| 2007-10-23 | 1217234 | CDNA | S-1 | Url |
CareDx, Inc(NASDAQ:CDNA) 
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It offers AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant pati...
Website: https://caredx.com/
Founded: 1998
Full Time Employees: 306
CEO: Reginald Seeto
Sector: Healthcare
Industry: Diagnostics & Research
The information provided in this report about CDNA stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.